- Advertisement -

Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval

Gilead Sciences chairman and CEO Daniel O’Day Eight months after it was first tested in human patients at the center of the world’s first COVID-19...

Illinois team develops first of a kind in-vitro 3D neural tissue model

Credit: University of Illinois Department of Bioengineering Researchers at the University of Illinois at Urbana-Champaign have successfully...

Critical Biospecimens 2023 Edition

View eBook  Biospecimens, and the data generated from them, remain the cornerstone of all therapeutic and diagnostic research and development. Several recent innovations have enabled...

Biotechnology is increasing yields of African yam bean – FreshPlaza.com

African scientists are using the tools of biotechnology to boost the climate-resiliency and yields of the high-protein African yam bean. Scientists at the International...

From lab to industry? Ideally ordered porous titania films, made at...

High-throughput double anodization to make ordered titania through-hole membranes Credit: Tokyo Metropolitan University Tokyo, Japan – Researchers from...

Precise DNA cleavage using new CRISPR-Cas approach

A team led by investigators at Massachusetts General Hospital (MGH) has overcome a major constraint for cutting and editing DNA by CRISPR-Cas enzymes and...

Decoding Resistance to Targeted Therapy via New Cancer Models

ATCC and the Broad Institute report the development of engineered isogenic cancer models designed to replicate resistance to targeted therapies, beginning with osimertinib, the...

10x Genomics Unveils Atera Spatial Platform at AACR Meeting

The genomics community’s long wait for 10x Genomics’ highly anticipated news is finally over. On Saturday night, at the Hard Rock Café Hotel in...

Decoding Resistance to Targeted Therapy via New Cancer Models

ATCC and the Broad Institute report the development of engineered isogenic cancer models designed to replicate resistance to targeted therapies, beginning with osimertinib, the...

10x Genomics Unveils Atera Spatial Platform at AACR Meeting

The genomics community’s long wait for 10x Genomics’ highly anticipated news is finally over. On Saturday night, at the Hard Rock Café Hotel in...

For What’s Next: Preparing Today’s Lab or Tomorrow’s Discoveries

Modern biology is accelerating at an unprecedented pace, and with it comes increasing complexity. As a result, researchers are shifting toward more patient reflective...

more new items

Decoding Resistance to Targeted Therapy via New Cancer Models

ATCC and the Broad Institute report the development of engineered isogenic cancer models designed to replicate resistance to targeted therapies, beginning with osimertinib, the...

10x Genomics Unveils Atera Spatial Platform at AACR Meeting

The genomics community’s long wait for 10x Genomics’ highly anticipated news is finally over. On Saturday night, at the Hard Rock Café Hotel in...

For What’s Next: Preparing Today’s Lab or Tomorrow’s Discoveries

Modern biology is accelerating at an unprecedented pace, and with it comes increasing complexity. As a result, researchers are shifting toward more patient reflective...